Several retrospective studies and meta-analyses of patients with rheumatoid arthritis treated with TNF inhibitors have shown that TNF inhibitors are not directly associated with the development of solid tumors, but the risk of developing non-melanoma skin cancer can be increased to 1.4- to 2- fold. Here, TNF is linked to rheumatoid arthritis.